{"id":"high-dose-erythropoietin","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Hypertension"},{"rate":"5-15","effect":"Thromboembolism"},{"rate":"10-20","effect":"Headache"},{"rate":"5-10","effect":"Fever"},{"rate":"rare","effect":"Pure red cell aplasia"},{"rate":"1-5","effect":"Seizures"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Erythropoietin (EPO) is a cytokine that binds to the erythropoietin receptor on erythroid progenitor and precursor cells, promoting their proliferation, differentiation, and survival. At high doses, it can enhance oxygen-carrying capacity of blood by increasing red blood cell mass. This mechanism has been explored therapeutically for anemia and experimentally for tissue protection in conditions with hypoxic injury.","oneSentence":"High-dose erythropoietin stimulates erythroid progenitor cells in bone marrow to increase red blood cell production and hemoglobin levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:47:49.744Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anemia associated with chronic kidney disease"},{"name":"Anemia in cancer patients receiving chemotherapy"},{"name":"Anemia of chronic disease"}]},"trialDetails":[{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT01732146","phase":"PHASE3","title":"Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-03-28","conditions":"Hypoxic Ischemic Encephalopathy","enrollment":120},{"nctId":"NCT00999583","phase":"PHASE3","title":"High Dose of Erythropoietin Analogue After Cardiac Arrest","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-10","conditions":"Comatose Survivors of Cardiac Arrest","enrollment":500},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT05617833","phase":"PHASE1","title":"Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-04-30","conditions":"Intraventricular Hemorrhage of Prematurity","enrollment":60},{"nctId":"NCT06854276","phase":"PHASE2","title":"Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2025-03-01","conditions":"Chemotherapy-induced Anemia, Non-myeloid Malignancies","enrollment":80},{"nctId":"NCT04707768","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects","status":"COMPLETED","sponsor":"Akebia Therapeutics","startDate":"2021-06-18","conditions":"Anemia Associated With Chronic Kidney Disease (CKD)","enrollment":456},{"nctId":"NCT01888445","phase":"PHASE2","title":"A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2013-03-28","conditions":"Renal Anemia Associated With Chronic Renal Failure (CRF)","enrollment":130},{"nctId":"NCT03263091","phase":"PHASE3","title":"Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden","status":"TERMINATED","sponsor":"Kyntra Bio","startDate":"2018-01-29","conditions":"Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts), Anemia","enrollment":184},{"nctId":"NCT01471015","phase":"PHASE1, PHASE2","title":"Darbe Administration in Newborns Undergoing Cooling for Encephalopathy","status":"COMPLETED","sponsor":"University of Utah","startDate":"2012-09","conditions":"Hypoxic Ischemic Encephalopathy","enrollment":30},{"nctId":"NCT05768997","phase":"PHASE3","title":"High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia","status":"UNKNOWN","sponsor":"Hallym University Medical Center","startDate":"2023-03-01","conditions":"Anemia","enrollment":312},{"nctId":"NCT02811263","phase":"PHASE3","title":"High-dose Erythropoietin for Asphyxia and Encephalopathy","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-01","conditions":"Neonatal Encephalopathy, Birth Asphyxia","enrollment":500},{"nctId":"NCT04885647","phase":"PHASE2","title":"A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease","status":"COMPLETED","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2021-03-12","conditions":"Renal Anemia of Chronic Kidney Disease","enrollment":60},{"nctId":"NCT05629598","phase":"PHASE2","title":"A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .","status":"UNKNOWN","sponsor":"Angde Biotech Pharmaceutical Co., Ltd.","startDate":"2022-04-13","conditions":"Renal Anemia","enrollment":150},{"nctId":"NCT05211167","phase":"PHASE3","title":"Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure","status":"UNKNOWN","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2021-07-01","conditions":"Kidney Failure, Chronic, Hemodialysis","enrollment":300},{"nctId":"NCT02052310","phase":"PHASE3","title":"Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants","status":"COMPLETED","sponsor":"Kyntra Bio","startDate":"2014-02-11","conditions":"Anemia in Incident Dialysis Patients","enrollment":1043},{"nctId":"NCT01378273","phase":"PHASE3","title":"Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-12","conditions":"Extreme Prematurity","enrollment":941},{"nctId":"NCT03277183","phase":"PHASE4","title":"Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2017-11-02","conditions":"Anemia, CKD, Atherosclerosis","enrollment":5},{"nctId":"NCT03950687","phase":"PHASE2","title":"Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis","status":"UNKNOWN","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2019-06-24","conditions":"Chronic Renal Failure With Hemodialysis","enrollment":150},{"nctId":"NCT00470210","phase":"PHASE4","title":"Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2007-05","conditions":"Hepatitis C, HIV Infections","enrollment":10},{"nctId":"NCT00071799","phase":"PHASE3","title":"A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care","status":"COMPLETED","sponsor":"Celgene","startDate":"2003-11-01","conditions":"Myelodysplastic Syndromes","enrollment":358},{"nctId":"NCT01010802","phase":"PHASE1","title":"Safety Study of Erythropoietin (EPO) in Parkinson's Disease","status":"COMPLETED","sponsor":"International Center for Neurological Restoration, Cuba","startDate":"2008-08","conditions":"Parkinson Disease","enrollment":10},{"nctId":"NCT02817555","phase":"PHASE4","title":"Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients","status":"COMPLETED","sponsor":"Andrea L Woodland","startDate":"2010-09","conditions":"Anemia, Chronic Kidney Disease","enrollment":50},{"nctId":"NCT03887065","phase":"EARLY_PHASE1","title":"Magnetic Resonance Imaging Study of JM-4 in Multiple Sclerosis/Clinically Patients","status":"UNKNOWN","sponsor":"Cook, Stuart, MD","startDate":"2019-06-15","conditions":"Multiple Sclerosis","enrollment":15},{"nctId":"NCT03835507","phase":"PHASE1, PHASE2","title":"Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis","status":"UNKNOWN","sponsor":"Hanyang University Seoul Hospital","startDate":"2016-06-20","conditions":"Amyotrophic Lateral Sclerosis","enrollment":64},{"nctId":"NCT01817699","phase":"PHASE4","title":"Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients","status":"TERMINATED","sponsor":"CANDLE-KIT Trial Study Group","startDate":"2013-04","conditions":"Kidney Transplantation, Anemia, Vitamin D Deficiency","enrollment":161},{"nctId":"NCT00052221","phase":"NA","title":"Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2003-05-20","conditions":"Fatigue, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":""},{"nctId":"NCT00413946","phase":"PHASE2","title":"Does Erythropoietin Improve Outcome in Very Preterm Infants?","status":"COMPLETED","sponsor":"Swiss Neonatal Network","startDate":"2006-01","conditions":"Intracranial Hemorrhage, Periventricular Leukomalacia, Cerebral Palsy","enrollment":420},{"nctId":"NCT02439697","phase":"NA","title":"A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2015-11","conditions":"Anemia, End Stage Renal Failure on Dialysis","enrollment":50},{"nctId":"NCT01581073","phase":"PHASE3","title":"PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease","status":"COMPLETED","sponsor":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","startDate":"2012-02-16","conditions":"Chronic Kidney Disease, Diabetes","enrollment":476},{"nctId":"NCT00400686","phase":"NA","title":"Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2003-09","conditions":"Anemia, Multiple Myeloma, Plasma Cell Neoplasm","enrollment":31},{"nctId":"NCT00717366","phase":"PHASE2","title":"Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2008-07","conditions":"Renal Anemia","enrollment":64},{"nctId":"NCT00017004","phase":"PHASE3","title":"Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia","status":"COMPLETED","sponsor":"Gynecologic Oncology Group","startDate":"2001-08","conditions":"Anemia, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma","enrollment":114},{"nctId":"NCT03102021","phase":"PHASE2","title":"The Effect of Human Recombinant Erythropoietin in Acute Renal Failure","status":"COMPLETED","sponsor":"North Texas Veterans Healthcare System","startDate":"2006-03","conditions":"Acute Kidney Injury","enrollment":25},{"nctId":"NCT02767765","phase":"PHASE3","title":"A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2003-06","conditions":"Anemia","enrollment":61},{"nctId":"NCT00248339","phase":"PHASE3","title":"Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2002-05","conditions":"Hepatitis C","enrollment":150},{"nctId":"NCT01450878","phase":"PHASE3","title":"Renal Graft Function After Treatment With Erythropoietin (EPO)","status":"TERMINATED","sponsor":"University Hospital, Limoges","startDate":"2011-12","conditions":"Ischemia","enrollment":6},{"nctId":"NCT00827021","phase":"PHASE3","title":"The Clinical Evaluation of the Dose of Erythropoietins Trial","status":"COMPLETED","sponsor":"Giovanni FM Strippoli, MD","startDate":"2009-07","conditions":"Kidney Failure, Chronic","enrollment":656},{"nctId":"NCT00815867","phase":"PHASE3","title":"Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2007-10","conditions":"Kidney Failure","enrollment":108},{"nctId":"NCT00577096","phase":"NA","title":"Effects of Exercise in Combination With Epoetin Alfa","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2001-10","conditions":"Multiple Myeloma","enrollment":120},{"nctId":"NCT02356419","phase":"PHASE1","title":"rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics","status":"UNKNOWN","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2014-09","conditions":"Chronic Renal Failure","enrollment":40},{"nctId":"NCT00662220","phase":"PHASE3","title":"High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4","status":"TERMINATED","sponsor":"Foundation for Liver Research","startDate":"2008-04","conditions":"Chronic Hepatitis C","enrollment":110},{"nctId":"NCT00542568","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Sustained Erythropoietin Therapy","status":"COMPLETED","sponsor":"Medgenics Medical Israel Ltd.","startDate":"2008-08","conditions":"Anemia","enrollment":19},{"nctId":"NCT01584921","phase":"PHASE1","title":"Renal Effects of Erythropoietin in Humans","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2012-03","conditions":"Renal Effects","enrollment":16},{"nctId":"NCT00589953","phase":"PHASE2","title":"High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study","status":"TERMINATED","sponsor":"Atlantic Health System","startDate":"2007-07","conditions":"Infant, Premature, Erythropoietin, Brain Injury","enrollment":22},{"nctId":"NCT01265680","phase":"NA","title":"Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery","status":"COMPLETED","sponsor":"Cardiochirurgia E.H.","startDate":"2012-02","conditions":"Blood Transfusion","enrollment":600},{"nctId":"NCT01665781","phase":"PHASE4","title":"Erythropoietin in the Prevention of Acute Mountain Sickness","status":"COMPLETED","sponsor":"University of Ulsan","startDate":"2012-08","conditions":"Acute Mountain Sickness","enrollment":39},{"nctId":"NCT00005787","phase":"PHASE1","title":"Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Northwestern University","startDate":"1999-09","conditions":"Lymphoma, Neutropenia","enrollment":3},{"nctId":"NCT00830609","phase":"PHASE4","title":"High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3","status":"COMPLETED","sponsor":"Dr. Conrado Fernandez","startDate":"2008-11","conditions":"Chronic Hepatitis C","enrollment":101},{"nctId":"NCT01548495","phase":"","title":"Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients","status":"UNKNOWN","sponsor":"yair levy","startDate":"2012-05","conditions":"Myelodysplatic Syndrome","enrollment":100},{"nctId":"NCT00938314","phase":"PHASE2","title":"Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients","status":"TERMINATED","sponsor":"Stem Cell Therapeutics Corp.","startDate":"2009-08","conditions":"Stroke","enrollment":96},{"nctId":"NCT00944684","phase":"PHASE2","title":"High Dose Ribavirin in the Treatment of Chronic Hepatitis C","status":"COMPLETED","sponsor":"University of Bern","startDate":"2007-11","conditions":"Chronic Hepatitis C","enrollment":32},{"nctId":"NCT00338416","phase":"PHASE2","title":"An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2003-03","conditions":"Cancer, Anemia","enrollment":115},{"nctId":"NCT00337948","phase":"PHASE2","title":"An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2003-02","conditions":"Chemotherapy, Anemia, Cancer","enrollment":129},{"nctId":"NCT00719498","phase":"PHASE3","title":"Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)","status":"COMPLETED","sponsor":"Janssen Cilag S.A.S.","startDate":"2003-11","conditions":"Resuscitation, Cardiopulmonary, Cardiac Arrest","enrollment":20},{"nctId":"NCT00557817","phase":"PHASE2, PHASE3","title":"Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)","status":"COMPLETED","sponsor":"University of Liege","startDate":"2004-03","conditions":"Hematological Malignancies","enrollment":125},{"nctId":"NCT00910234","phase":"PHASE1, PHASE2","title":"Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants","status":"UNKNOWN","sponsor":"China Medical University Hospital","startDate":"2009-08","conditions":"Infant, Premature, Leukomalacia, Periventricular, Intraventricular Hemorrhage","enrollment":100},{"nctId":"NCT00204633","phase":"PHASE2","title":"Darbepoetin Alfa in Patients With \"Poor Prognosis\" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2003-07","conditions":"Dysgerminoma","enrollment":108},{"nctId":"NCT00526448","phase":"PHASE4","title":"Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients","status":"UNKNOWN","sponsor":"Hospital Carlos III, Madrid","startDate":"2007-06","conditions":"Chronic Hepatitis C","enrollment":384},{"nctId":"NCT00491413","phase":"PHASE1","title":"Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth","status":"UNKNOWN","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"","conditions":"Asphyxia","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":118,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["High dose"],"phase":"marketed","status":"active","brandName":"High dose erythropoietin","genericName":"High dose erythropoietin","companyName":"VA Office of Research and Development","companyId":"va-office-of-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"High-dose erythropoietin stimulates erythroid progenitor cells in bone marrow to increase red blood cell production and hemoglobin levels. Used for Anemia associated with chronic kidney disease, Anemia in cancer patients receiving chemotherapy, Anemia of chronic disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}